Researchers developed COMET, a deep learning framework that leverages electronic health records and omics data to improve predictive modeling and uncover biological insights.
Researchers find powerful combo weapon against aggressive lymphoma
The targeted therapy combination of ibrutinib and venetoclax significantly improved progression-free survival (PFS) and achieved an overall remission rate in 82% of patients with relapsed/refractory
December 13, 2023